Targeted β‐catenin ubiquitination and degradation by multifunctional stapled peptides
- 22 December 2021
- journal article
- research article
- Published by Wiley in Journal of Peptide Science
- Vol. 28 (7) , e3389
Abstract
Aberrant activation of the Wnt signaling pathway has been identified in numerous types of cancer. One common feature of oncogenic Wnt regulation involves an increase in the cellular levels of β‐catenin due to interference with its constitutive ubiquitin‐dependent degradation. Targeting β‐catenin has therefore emerged as an appealing approach for the treatment of Wnt‐dependent cancers. Here, we report a strategy that employs multifunctional stapled peptides to recruit an E3 ubiquitin ligase to β‐catenin, thereby rescuing β‐catenin degradation by hijacking the endogenous ubiquitin‐proteasome pathway. Specifically, we designed, synthesized, and evaluated a panel of multifunctional stapled peptides that have a β‐catenin binding moiety (StAx‐35) covalently linked to a second stapled peptide moiety (SAH‐p53‐8), which is capable to interact with the E3 ubiquitin ligase MDM2. We found that in vitro these multifunctional peptides can recruit the MDM2 protein to β‐catenin and induce poly‐ubiquitination on β‐catenin. In cellulo, treatment of the human colorectal cancer cell line SW480 with the multifunctional stapled peptides showed dose‐dependent degradation of endogenous β‐catenin levels. In addition, a luciferase reporter assay showed that the multifunctional stapled peptides can suppress β‐catenin‐mediated gene expression via the Wnt signaling pathway. Therefore, these multifunctional stapled peptides provide a unique research tool for examining the Wnt signaling pathway by targeted knockdown of β‐catenin at the protein level, and may serve as leads for potential drug candidates in the treatment of Wnt‐dependent cancers.Keywords
Funding Information
- GlaxoSmithKline
- China Pharmaceutical University
This publication has 42 references indexed in Scilit:
- Inhibition of oncogenic Wnt signaling through direct targeting of β-cateninProceedings of the National Academy of Sciences, 2012
- Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt SignalingScience Translational Medicine, 2012
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1αNature Chemical Biology, 2010
- Direct inhibition of the NOTCH transcription factor complexNature, 2009
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signallingNature, 2009
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancerNature Chemical Biology, 2009
- Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomicsBioorganic & Medicinal Chemistry Letters, 2008
- Recognition of the polyubiquitin proteolytic signalThe EMBO Journal, 2000